|
Volumn 20, Issue 49 REV. IIS. 6, 2001, Pages 7136-7139
|
APL, a model disease for cancer therapies?
|
Author keywords
Apoptosis; Arsenic; Differentiation; Leukemia; PML RAR ; Retinoic acid
|
Indexed keywords
ANTHRACYCLINE;
ARSENIC;
HORMONE RECEPTOR;
RETINOIC ACID;
RETINOIC ACID RECEPTOR;
TELOMERASE;
UBIQUITIN;
ACUTE MYELOBLASTIC LEUKEMIA;
ANIMAL MODEL;
APOPTOSIS;
CANCER THERAPY;
CARCINOGENESIS;
CELL DIFFERENTIATION;
CHROMOSOME TRANSLOCATION 15;
DIMERIZATION;
DNA BINDING;
GENE REARRANGEMENT;
LEUKEMIA REMISSION;
MALIGNANT TRANSFORMATION;
PRIORITY JOURNAL;
REVIEW;
TRANSCRIPTION REGULATION;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
CELL AGING;
CELL DIFFERENTIATION;
CELL NUCLEUS;
HUMANS;
INCLUSION BODIES;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MULTIGENE FAMILY;
NEOPLASM PROTEINS;
ONCOGENE PROTEINS, FUSION;
OXIDES;
RECEPTORS, RETINOIC ACID;
TRETINOIN;
ANIMALIA;
|
EID: 0035969096
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204851 Document Type: Review |
Times cited : (21)
|
References (26)
|